Why Palantir Stock Is Tumbling Tuesday

Palantir (PLTR) shares tumbled over 9% to close just under $158, extending a five-day decline, as short seller Andrew Left of Citron Research fueled overvaluation concerns by asserting the stock, despite more than doubling in 2025 on strong AI demand, is 'detached from fundamentals' and worth only $40 based on a comparison to OpenAI's price-to-revenue multiple. This sentiment is largely echoed by Wall Street analysts, with most holding 'neutral' ratings and highlighting that the stock appears 'priced for perfection' and its valuation 'disconnected from even optimistic growth scenarios,' signaling potential for further correction.

Analysis

Palantir (PLTR) shares experienced a significant downturn, falling over 9% to under $158 and marking a fifth consecutive day of losses, directly following a critical report from short-seller Citron Research. Despite being the S&P 500's best-performing stock in 2025 with a more than 100% gain driven by record sales from its AI platform, the stock's valuation is now under intense scrutiny. Citron's Andrew Left argues the stock is "detached from fundamentals," proposing a price target of $40 based on a comparative price-to-revenue multiple against OpenAI. This bearish sentiment is not isolated; a majority of Wall Street analysts surveyed by Visible Alpha maintain "hold" ratings, reflecting broader concern. Jefferies analysts, while acknowledging strong revenue and outlook, view the valuation as "disconnected from even optimistic growth scenarios." Similarly, HSBC analysts caution that the stock may be "priced for perfection," indicating a high risk of underperformance if the company fails to exceed already elevated investor expectations.

Key Decisions for Investors

• Given the stock has more than doubled in 2025, investors with significant gains may consider trimming their positions to de-risk and crystallize profits, as mounting valuation concerns from both short-sellers and mainstream analysts signal potential for further downside.
• Potential buyers should exercise caution, as the sharp sell-off is driven by credible valuation critiques; waiting for a period of price consolidation or the next earnings report to re-validate the growth narrative could be a prudent strategy.
• Monitor future earnings reports closely for any deceleration in growth, as the stock's current valuation leaves no room for operational missteps or failure to meet the market's exceptionally high expectations.